Ligand · 4D9
4D9 · 3-(1H-benzimidazol-2-yl)-N-(1-benzothiophen-2-ylcarbonyl)-D-alanine
4D9, 3-(1H-benzimidazol-2-yl)-N-(1-benzothiophen-2-ylcarbonyl)-D-alanine (C19 H15 N3 O3 S, 365.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- 4D9
- Formula
- C19 H15 N3 O3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
4D9 in 2 structures; the first of them:
- 3KAF · Structure-guided design of alpha-amino acid-derived Pin1 inhibitors · 4D9 A164 · binds HIS59, LEU61, LYS63, ARG69, CYS113, SER114, SER115, LEU122 and 6 more
- 3KAF · Structure-guided design of alpha-amino acid-derived PIN1 inhibitors · 4D9 A164 · binds HIS59, LEU61, LYS63, ARG69, CYS113, SER114, SER115, LEU122 and 6 more
Residues it binds most
SER 2, HIS 2, LEU 2, ALA 2, ARG 2, CYS 2, LYS 2, MET 2, PHE 2, THR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.